SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
25-Apr-18 4:58 PM View: | Argos Therapeutics Inc (ARGS) | 25-Apr-18 | Disposition | 22,629 | -- | -- | (66%) 34.41K to 11.78K | |
30-Mar-18 5:14 PM View: | Argos Therapeutics Inc (ARGS) | 28-Mar-18 | Grant | 22,629 | -- | -- | 192% 11.78K to 34.41K | |
12-Jan-18 2:01 PM View: | Argos Therapeutics Inc (ARGS) | 09-Jan-18 | Market Sale (Planned) | 64,329 | $0.16 | $10,595.00 | (22%) 295.31K to 230.98K | 92% |
05-Jan-18 11:56 AM View: | Argos Therapeutics Inc (ARGS) | 03-Jan-18 | Market Sale (Planned) | 59,072 | $0.16 | $9,658.27 | (17%) 354.38K to 295.31K | 99% |
31-Aug-17 7:04 PM View: | Argos Therapeutics Inc (ARGS) | 30-Aug-17 | Grant | 320,683 | -- | -- | 952% 33.7K to 354.38K | |
23-Jan-17 3:57 PM View: | Argos Therapeutics Inc (ARGS) | 20-Jan-17 | Grant | 3,694 | -- | -- | 12% 30.0K to 33.7K | |
12-Jan-16 9:22 AM View: | Argos Therapeutics Inc (ARGS) | 08-Jan-16 | Grant | 28,125 | -- | -- | 1496% 1.88K to 30.0K |